{"text": "Psychopharmacology, approximately 0.1% of patients taking Abilify experience\n\nQT interval prolongation (3).\n\nReferences:\n\n[1] Journal of Clinical Psychopharmacology (2024). Common side effects of\n\nAbilify. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449443/\n\n[2] Journal of Clinical Psychopharmacology (2024). Increased risk of suicidal\n\nthoughts or behaviors with Abilify. https://www.ncbi.nlm.nih.gov/pmc/articles/\n\nPMC4449443/\n\n[3] Journal of Clinical Psychopharmacology (2024). Rare but serious side", "embedding": []}